MAY 31, 2017 04:56 PM PDT

Quitting Methamphetamine Abuse Can Reverse Heart Damage

WRITTEN BY: Kara Marker

It’s possible to reverse the damaging effects of methamphetamine abuse on the heart by quitting the drug when it’s accompanied with some medical treatment. In a study from the American College of Cardiology, researchers are interested in showing how drug abuse cessation can help people avoid both short-term and long-term “cardiovascular consequences.”

Credit: Discovery Place

Methamphetamines are among some of the most commonly used drugs worldwide. Past research links their use to heart problems, and the present study is one of the first to provide evidence that these heart conditions can be reversed.

“Methamphetamine associated cardiac myopathy will become a growing cause of heart failure in young adults," explained Norman Mangner, MD, senior author of the study. "Due to the chance to recover cardiac function and symptoms at an early stage of the disease, early detection of heart problems in patients with methamphetamine abuse could prevent further deterioration of the cardiomyopathy."

In a study of 30 people currently abusing methamphetamines at the start of the experiment, researchers began to show how quitting the drug could reverse some heart damage. All of the study participants showed evidence of heart failure, specifically a left ventricular ejection fraction of less than 40 percent. Also, a large majority had trouble breathing, and one-third showed signs of intracardiac blood clots.


Along with quitting the abuse of methamphetamines, the experimental group of drug abusers received certain medical treatments: automatic implantable cardioverter-defribillator and other “supportive measures and guideline-supported medical therapy.”

Results from quitting drug use and following drug therapy guidelines included: improved cardiac function, lower incidence of non-fatal stroke and rehospitalization for heart failure.

"Rather than simply placing patients with suspected methamphetamine associated cardiomyopathy on a cocktail of neurohormonal blockade, the majority of focus should be on helping such patients quit," said James L. Januzzi, MD, of the study in an editorial.

The present study was published in JACC: Heart Failure.

Source: American College of Cardiology


About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
NOV 22, 2019
NOV 22, 2019
Immune System Responsible for Organ Failure in Malaria
In the most severe cases of malaria, a person can experience organ failure and die. Often times, though, this is not directly due to the parasitic malaria ...
NOV 22, 2019
Drug Discovery & Development
NOV 22, 2019
Common Therapeutic Can Treat Bleeding Associated with Traumatic Brain Injury
An inexpensive and accessible drug was found to reduce rates of mortality associated with traumatic brain injury (TBI) patients by 20%. TBI is a major caus...
NOV 22, 2019
Health & Medicine
NOV 22, 2019
An Avocado a Day for Heart Health
There’s more great news for avocado lovers! The beloved tree fruit has undoubtedly skyrocketed in popularity over the last few decades thanks to a mu...
NOV 22, 2019
Cannabis Sciences
NOV 22, 2019
Zebrafish Development Thwarted by Blocked Cannabinoids
Cannabinoid receptors of the endocannabinoid system (ECS) are vital pieces of the puzzle for the ECS to function correctly; the ECS needs cannabinoid recep...
NOV 22, 2019
NOV 22, 2019
An astronaut's training for cancer patients
The comparison is perhaps unexpected, but the findings show potential: astronauts experience similar physical stress in spaceflight as cancer patients rece...
NOV 22, 2019
Cannabis Sciences
NOV 22, 2019
Feds Warn CBD Companies About Health Claims, Demand Response
Two federal agencies are alerting CBD companies that their marketing claims are illegal. The FTC and FDA sent out letters to several CDB companies deemed t...
Loading Comments...